Biological activity of quinoxaline derivatives

International Journal of Current Pharmaceutical Review and Research

Volumn 2, Issue 1, 2011, Pages 33-46

  Deepika, Yadav ^a   Nath, Pandeya Surendra ^a   Sachin, Kumar ^b   Shewta, Sinha ^a  

^a Saroj Institute of Technology and Management   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

1; 4 di N Oxide; Antibacterial; Anticancerous; Antineoplastic; Quinoxaline

Indexed keywords

(N ARYLCARBAMOYL)HYDRAZINEQUINOXALIN; (N ARYLTHIOCARBAMOYL)HYDRAZINEQUINOXALIN; 2 HYDROXYMETHYL 3 METHYLQUINOXALINE 1,4 DI N OXIDE; 2,3 BIS(BROMOMETHYL) 5,10 BENZO[G]QUINOXALINEDIONE; 2,3 DIMETHYL 6 (2 DIMETHYLAMINOETHYL) 6H INDOLO[2,3 B]QUINOXALINE; 2,3 DIMETHYL 6 (DIMETHYLAMINOETHYL) 6H INDOLO[2,3 B]QUINOXALINE; 2,3 DIMETHYLQUINOXALINE 1,4 DI N OXIDE; 2,3,7,8 TETRAKIS(PYRIDYL)PYRAZINO[2,3 G]QUINOXALINE; 6 ARYLAMINO 2,3 BIS(PYRIDIN 2 YL) 7 CHOLOROQUINOXALINE 5,8 DIONE DERIVATIVE; 7 DIALKYLAMINOMETHYLBENZO[G]QUINOXALINE 5,10 DIONE DERIVATIVE; ANTIAMEBIC AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIGLAUCOMA AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BENZO[G]QUINOXALINE 5,10 DIONE DERIVATIVE; BRIMONIDIN; CARBADOX; CYTOTOXIC AGENT; PHENOXYMETHYLQUINOXALINE DERIVATIVE; PYRAZOLOQUINOXALINE; PYRIDINE 2 CARBOXYLIC ACID N (7 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL)HYDRAZIDE; PYRIDO[2,3 G]QUINOXALINE DERIVATIVE; QUINOXALINE 1,4 DI N OXIDE DERIVATIVE; QUINOXALINE DERIVATIVE; THIAZOLO[4,5 B]QUINOXALINE 2 YL HYDRAZONE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BACTERIAL INFECTION; CANCER INHIBITION; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; GLAUCOMA; HUMAN; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 79955713984     PISSN: None     EISSN: 0976822X     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Misskire, Yohannes. Synthesis and Characterization of metal complexes of a new heterocyclic Ligand, Addis Ababa University, 2006.
2. Xian-He Bu, He Liu, Miao Du, Keith Man-Chung Wong, Vivian-Wing-Wah Yam, Mitsuhiko Shionoya. Novel Boxline Dinuclear Or Chain Polymeric Silver(I) Complexes With Polypyridyl Bridging Ligands: An Overview.Inorganic Chem.2001;40:4143-4149.
3. Dell A, William D.H, Morris H.R, G.A. Smith G.A., Feeney J, Roberts G.C.K. Structure Revision of the Antibiotic Echinomycin.J. Am. Chem. Soc.1975; 97:2497-2502.
4. M.Suresh, P.Lavanya, D.Sudhakar, K.Vasu, C.Venkata Rao. Synthesis and Biological Activity of 8-Choloro-[1, 2, 4]triazolo [4, 3-a] quinoxalines. J.Chem.Pharm.Res;2010, 2(1):497-504.
5. Zhu Z, Saluja S, Drach J.C, Townsend L.B. Synthesis of imidazo [4, 5-b] quinoxaline ribonucleosides as linear dimensional analogues of antiviral polyhalogenated benzimidazole ribo-nucleosides.J.Chinese Chem.Soc.1998;45:465-474.
6. Campiani G, Aiello F, Fabbrini M, Morelli E, Ramunno A, Armaroli S, Nacci V, Garofalo A, Greco G, Novellino E, Maga G, Spadari S, Bergamini A, Ventura L, Bongiovanni B, Capozzi M, Bolacchi F, Marini S, Coletta M, Guiso G, Caccia S. Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. J Med Chem. 2001;44(3):305-315.
7. Francis J, Landquist J.K, levi, A.A, Silk J.A. & Thorpe. J.M. 2 Hydroxymethyl-3-methylquinoxaline 1:4-dioxide: a metabolite of 2:3-dimethylquinoxaline 1:4-dioxide active against Gram-negative bacteria J. Biochem.1956;64:455-457.
8. Carta Antonio, Paglietti Giuseppe, Mohammad E. Rahbar Nikookar, Paolo Sanna, Leonardo Sechi, and Zanetti Stefania. Novel substituted quinoxaline 1, 4-dioxides with in vitro antimycobacterial and anticandida activity.Eur. J. Med. Chem.2002; 37:355-366.
9. Kurasawa Yoshihisa, Muramatsu Muneto, Yamazaki Kaoru, Okamoto Yoshihisa, Takada Atsushi. Synthesis of 3-(α chlorophenylhydrazono)heteroarylmethyl-2-oxo-1, 2 dihydroquinoxalines with antimicrobial activity.J. Heterocyclic Chem, 1986; 23:1387-1390.
10. Li J.J. Synthesis of Novel 3-substituted Pyrrolo[2, 3-b] quinoxalines via an intermolecular Heck Reaction on an Aminoquinoxaline Scaffold.J.Org.Chem.1999; 64:8425-8427.
11. Belen Z, Andres J, Ignacio A. & Antonio M. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1, 4-di-N-oxide derivatives.Bioorg. & Med.Chem.2004;12:3711-3721.
12. Dirlam, JP, Presslitz JE & Williams BJ. Synthesis and antibacterial activity of some 3-[(alkylthio) methyl] quinoxaline 1-oxide derivatives.J.Med.Chem.1983;26(8):1122-1126.
13. A.K. Salman, Kishwar S, K Zaheer. Synthesis, characterization and in vitro antibacterial activity of new steroidal thiazolo quinoxalines.Eur.J.Med.Chem.2007; 42: 103-108.
14. KT Vishnu, BY Dharmendra, KM Hardesh, KC Ashok & KS Praveen. Design, synthesis, and biological evaluation of 1, 2, 3-trisubstituted-1, 4-dihydrobenzo[g]quinoxaline-5, 10-diones and related compounds as antifungal and antibacterial agents. Bioorg.Med.Chem.2006;14:6120-6126.
15. Reddy Sastry, CV Marwah, P Marwah, A. K & Rao G. S. Synthesis and biological activity of some new N-arylcarbamoyl and arylthiocarbamoyl hydrazinoquinoxalin-2-ones.Indian. J. Chem.1989;28B:885-891
16. Sanna Paolo, Carta Antonio, Lorgia Mario, Zanetti Stefania, Sechi Leonardo. Preparation and biological evaluation of 6/7-trifluromethyl(nitro)-, 6, 7-difluro-3-alkyl(aryl)-substituted-quinoxalin-2-ones.ILFarmaco.1999;54:169-177.
17. Carta Antonio, Sanna Paolo, Gherardini Laura, Usai Donatella, Zanetti Stefania. Novel functionalized pyrido[2, 3-g]quinoxalines as antibacterial, antifungal and anticancer agents.ILFarmaco.2001;56:933-938.
18. G Fedora, A Francesca, G.D Osvaldo, B Antonella, G Antonio & N Nouri. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.Bioorg.Med.Chem.2007;15:288-294.
19. Lee Heesoon, Cho Sungmoon, Namgoong Kwon, Jung Kyung Jae-Kyung, Cho sook Jung, Yang Il Sung. Synthesis and in vitro evaluation of 7-dialkylaminomethylbenzo[g] quinoxaline-5, 10-diones.Bioorg & Med.Chem.2004;14:1235-1237.
20. Patel N, Bergman J, Graslund A. 1H-NMR studies of the interaction between a self-complementary deoxyoligonucleotide duplex and indolo[2, 3-b]quinoxaline derivatives active against herpes virus.Eur.J.Biochem.1991;197:597-604.
21. Monge A, Martinez - Grespo, FJ, Ceralin, A.l. Palop, J.A. Narro, S, Senador V., Marin A., Sainz Y., Gonzalez M., Hamilton E. & Barker A.J. Hypoxia-Selective Agents Derived from 2-quinoxalinecarbonitrile 1, 4-Di-n-Oxides. J. Med.Chem.1995;38:4488-4494.
22. Yoo HW, Suh ME & Park SW. Synthesis and Cytoxicity of 2-methyl-4, 9-dihydro-1-substituted-1H-imidazo[4, 5-g]quinoxaline-4, 9-diones and 2, 3-Disubstituted-5, 10-pyrazino[2, g]quinoxalinediones.J.Med.Chem.1998;41:4716-4722.
23. Refaat M.Hanan, Monner A.Ashraf, Khalil M. Omneya-Synthesis and Antimicrobial Activity of Certain Novel Quinoxalines.Arch Pharm Res.2004;11:1093-1098.
24. Chung Jin-Hwa, Jung Jai Ok, Chae Jin Mi, Hong Yu-Sung, Chung Hoe-Kwang, Lee Kook Sang, Chung Kyu Ryu-Synthesis and biological evaluation of quinoxaline-5, 8-diones that inhibit vascular smooth muscle cell proliferation.Biorganic & Medicinal Chemistry Letters 2005;15:3380-3384.
25. Budakoti Asha, Bhat Roouf Abdul, Azam Amir-Synthesis of new-2-(5-subsituted-3-phenyl-2-pyrazolinyl)-1, 3-thiazolino[5, 4-b] quinoxaline derivatives and evaluation of their antiameobic activity.European Journal of Medicinal Chemistry 2009;44:1317-1325.
26. Lawrence SD, Copper ET, Smith DC. Structure-Activity Studies of Substituted Quinoxalinones as Multiple-Drug-Resistance Antagonists.J.Med.Chem.2001;44:594-601.